investigators present updated results of the opacin trial for melanoma
Published 4 years ago • 78 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:39
opacin and opacin-neo: neoadjuvant immunotherapy for advanced melanoma
-
25:50
melanoma | 2022 oneoncology conference
-
27:18
adjuvant and neoadjuvant dilemmas
-
1:54
opacin-neo and prado: personalized neoadjuvant io for melanoma based on pathologic response
-
1:12
current trials in the treatment of melanoma
-
2:52
opacin-neo trial rfs and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma
-
1:34
opacin and opacin-neo trial updates
-
2:53
opacin-neo: tmb and ifn-γ identified as biomarkers of pathologic response in melanoma
-
1:13
clinical trials investigating the treatment of melanoma
-
1:16
neoadjuvant ipi nivo in stage iii melanoma: updates from opacin & opacin-neo
-
1:08
keynote-716: safety profile and results of pembrolizumab for melanoma
-
1:59
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
43:17
advanced melanoma
-
47:59
the future of melanoma: what to anticipate in 2023 with neoadjuvant and adjuvant pembrolizumab
-
10:42
what is new in melanoma?
-
0:57
circulating immune cell subsets in patients with melanoma from the opacin-neo trial
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
24:47
adjuvant and neoadjuvant therapy for melanoma weber 2021